{"id":"https://openalex.org/W2565083273","doi":"https://doi.org/10.5339/qfarc.2016.hbpp2578","title":"Differential Responsiveness to Braf Inhibitors of Melanoma Cell Lines Braf V600e-Mutated","display_name":"Differential Responsiveness to Braf Inhibitors of Melanoma Cell Lines Braf V600e-Mutated","publication_year":2016,"publication_date":"2016-01-01","ids":{"openalex":"https://openalex.org/W2565083273","doi":"https://doi.org/10.5339/qfarc.2016.hbpp2578","mag":"2565083273"},"language":"en","primary_location":{"id":"doi:10.5339/qfarc.2016.hbpp2578","doi":"https://doi.org/10.5339/qfarc.2016.hbpp2578","is_oa":false,"landing_page_url":"https://doi.org/10.5339/qfarc.2016.hbpp2578","pdf_url":null,"source":{"id":"https://openalex.org/S4306525075","display_name":"Qatar Foundation Annual Research Conference (ARC)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"conference"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Qatar Foundation Annual Research Conference Proceedings Volume 2016 Issue 1","raw_type":"proceedings-article"},"volume":null,"type":"conference-paper","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075926601","display_name":"Muna Al Hashmi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130525","display_name":"Sidra Medical and Research Center","ror":"https://ror.org/03acdk243","country_code":"QA","type":"healthcare","lineage":["https://openalex.org/I4210130525"]}],"countries":["QA"],"is_corresponding":false,"raw_author_name":"Muna Al Hashmi","raw_affiliation_strings":["1Sidra Medical and Research Center, QA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sidra Medical and Research Center, QA","institution_ids":["https://openalex.org/I4210130525"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085662152","display_name":"Konduru Seetharama Sastry","orcid":"https://orcid.org/0000-0002-2178-1892","observed_orcids":["https://orcid.org/0000-0002-2178-1892"]},"institutions":[{"id":"https://openalex.org/I4210130525","display_name":"Sidra Medical and Research Center","ror":"https://ror.org/03acdk243","country_code":"QA","type":"healthcare","lineage":["https://openalex.org/I4210130525"]}],"countries":["QA"],"is_corresponding":false,"raw_author_name":"Konduru Sastry","raw_affiliation_strings":["1Sidra Medical and Research Center, QA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sidra Medical and Research Center, QA","institution_ids":["https://openalex.org/I4210130525"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089938500","display_name":"Lee Silcock","orcid":"https://orcid.org/0009-0000-2806-1778","observed_orcids":["https://orcid.org/0009-0000-2806-1778"]},"institutions":[{"id":"https://openalex.org/I4210130525","display_name":"Sidra Medical and Research Center","ror":"https://ror.org/03acdk243","country_code":"QA","type":"healthcare","lineage":["https://openalex.org/I4210130525"]}],"countries":["QA"],"is_corresponding":false,"raw_author_name":"Lee Silcock","raw_affiliation_strings":["1Sidra Medical and Research Center, QA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sidra Medical and Research Center, QA","institution_ids":["https://openalex.org/I4210130525"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050542224","display_name":"Lotfi Chouchane","orcid":"https://orcid.org/0000-0002-2082-7924","observed_orcids":["https://orcid.org/0000-0002-2082-7924"]},"institutions":[{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lotfi Chouchane","raw_affiliation_strings":["2Weill Cornell Medical College, QA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Weill Cornell Medical College, QA","institution_ids":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Valentina Mattei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130525","display_name":"Sidra Medical and Research Center","ror":"https://ror.org/03acdk243","country_code":"QA","type":"healthcare","lineage":["https://openalex.org/I4210130525"]}],"countries":["QA"],"is_corresponding":false,"raw_author_name":"Valentina Mattei","raw_affiliation_strings":["1Sidra Medical and Research Center, QA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sidra Medical and Research Center, QA","institution_ids":["https://openalex.org/I4210130525"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029462216","display_name":"Barbara Seliger","orcid":"https://orcid.org/0000-0002-5544-4958","observed_orcids":["https://orcid.org/0000-0002-5544-4958"]},"institutions":[{"id":"https://openalex.org/I68956291","display_name":"Martin Luther University Halle-Wittenberg","ror":"https://ror.org/05gqaka33","country_code":"DE","type":"education","lineage":["https://openalex.org/I68956291"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Barbara Seliger","raw_affiliation_strings":["3Martin Luther University Halle-Wittenberg, QA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Martin Luther University Halle-Wittenberg, QA","institution_ids":["https://openalex.org/I68956291"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049816096","display_name":"Ena Wang","orcid":"https://orcid.org/0000-0001-6606-6510","observed_orcids":["https://orcid.org/0000-0001-6606-6510"]},"institutions":[{"id":"https://openalex.org/I4210130525","display_name":"Sidra Medical and Research Center","ror":"https://ror.org/03acdk243","country_code":"QA","type":"healthcare","lineage":["https://openalex.org/I4210130525"]}],"countries":["QA"],"is_corresponding":false,"raw_author_name":"Ena Wang","raw_affiliation_strings":["1Sidra Medical and Research Center, QA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sidra Medical and Research Center, QA","institution_ids":["https://openalex.org/I4210130525"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059941996","display_name":"Francesco Maria Marincola","orcid":"https://orcid.org/0000-0001-6423-391X","observed_orcids":["https://orcid.org/0000-0001-6423-391X"]},"institutions":[{"id":"https://openalex.org/I4210130525","display_name":"Sidra Medical and Research Center","ror":"https://ror.org/03acdk243","country_code":"QA","type":"healthcare","lineage":["https://openalex.org/I4210130525"]}],"countries":["QA"],"is_corresponding":false,"raw_author_name":"Francesco Marincola","raw_affiliation_strings":["1Sidra Medical and Research Center, QA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sidra Medical and Research Center, QA","institution_ids":["https://openalex.org/I4210130525"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048769007","display_name":"Sara Tomei","orcid":"https://orcid.org/0000-0001-5334-9140","observed_orcids":["https://orcid.org/0000-0001-5334-9140"]},"institutions":[{"id":"https://openalex.org/I4210130525","display_name":"Sidra Medical and Research Center","ror":"https://ror.org/03acdk243","country_code":"QA","type":"healthcare","lineage":["https://openalex.org/I4210130525"]}],"countries":["QA"],"is_corresponding":false,"raw_author_name":"Sara Tomei","raw_affiliation_strings":["1Sidra Medical and Research Center, QA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sidra Medical and Research Center, QA","institution_ids":["https://openalex.org/I4210130525"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.24413844,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11173","display_name":"Neurofibromatosis and Schwannoma Cases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9739999771118164},{"id":"https://openalex.org/keywords/braf-v600e-mutation","display_name":"BRAF V600E mutation","score":0.9940000176429749},{"id":"https://openalex.org/keywords/braf-inhibitors","display_name":"BRAF inhibitors","score":0.9769999980926514},{"id":"https://openalex.org/keywords/vemurafenib","display_name":"vemurafenib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/plx4720","display_name":"PLX4720","score":0.9919999837875366},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9879999756813049},{"id":"https://openalex.org/keywords/erk-signaling","display_name":"ERK signaling","score":0.8460000157356262},{"id":"https://openalex.org/keywords/melanoma-cell-lines","display_name":"melanoma cell lines","score":0.8489999771118164},{"id":"https://openalex.org/keywords/mapk-pathway-activation","display_name":"MAPK pathway activation","score":0.7820000052452087},{"id":"https://openalex.org/keywords/cell-proliferation","display_name":"cell proliferation","score":0.6850000023841858},{"id":"https://openalex.org/keywords/targeted-therapy-response","display_name":"targeted therapy response","score":0.5419999957084656}],"concepts":[{"id":"https://openalex.org/C76818968","wikidata":"https://www.wikidata.org/wiki/Q181940","display_name":"Sanger sequencing","level":4,"score":0.7764216661453247},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.712131679058075},{"id":"https://openalex.org/C21790070","wikidata":"https://www.wikidata.org/wiki/Q18030215","display_name":"Neuroblastoma RAS viral oncogene homolog","level":5,"score":0.7113944888114929},{"id":"https://openalex.org/C2776470698","wikidata":"https://www.wikidata.org/wiki/Q21851559","display_name":"V600E","level":4,"score":0.6711128354072571},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6556814312934875},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6109071373939514},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.5624226927757263},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.5441319942474365},{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.468961626291275},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4242198169231415},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.41844138503074646},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.40950971841812134},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.3819444477558136},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.23951902985572815},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.1521833837032318},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.5339/qfarc.2016.hbpp2578","doi":"https://doi.org/10.5339/qfarc.2016.hbpp2578","is_oa":false,"landing_page_url":"https://doi.org/10.5339/qfarc.2016.hbpp2578","pdf_url":null,"source":{"id":"https://openalex.org/S4306525075","display_name":"Qatar Foundation Annual Research Conference (ARC)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"conference"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Qatar Foundation Annual Research Conference Proceedings Volume 2016 Issue 1","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8560000061988831}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W6958340349","https://openalex.org/W1179952421","https://openalex.org/W7096371710","https://openalex.org/W1983939403","https://openalex.org/W2108537717","https://openalex.org/W2050989745","https://openalex.org/W2319724983","https://openalex.org/W2112934459","https://openalex.org/W7055709095","https://openalex.org/W2408002696"],"abstract_inverted_index":{"Background":[0],"Melanoma":[1],"is":[2,23,112],"an":[3],"aggressive":[4],"neoplasm":[5],"characterized":[6],"by":[7,65,286,367],"a":[8,71,336,372,425],"complex":[9],"etiology.":[10],"Several":[11],"molecular":[12],"alterations":[13],"occur":[14],"during":[15],"melanoma":[16,139],"progression.":[17],"The":[18,30,75,247,314,348],"most":[19],"commonly":[20],"mutated":[21,178],"pathway":[22,311,332],"the":[24,33,58,87,101,115,146,170,174,180,200,207,211,223,236,325,342,352,380,389,399,407,418],"mitogen-activated":[25],"protein":[26,305,328,431],"kinases":[27],"(MAPK)/ERK":[28],"cascade.":[29],"activation":[31,333],"of":[32,61,73,77,96,104,117,196,206,281,351],"MAPK/ERK":[34],"signaling":[35],"occurs":[36],"either":[37],"through":[38,47],"gain-of-function":[39],"mutations":[40,53,79,405],"in":[41,57,86,108,145,204,219],"BRAF":[42,62,98,105,123,156,197,213,238,241,253,257,266,270,301,320,343,373,381,390,403,414,427],"and":[43,68,129,155,199,240,255,274,276,293,304,307,327,330,361,417,430],"NRAS":[44],"gene":[45,63],"or":[46],"autocrine":[48],"growth":[49],"factor":[50],"stimulation.":[51],"Documented":[52],"have":[54],"been":[55],"found":[56,135],"kinase":[59],"domain":[60],"encoded":[64],"exon":[66],"11":[67],"15":[69,138],"with":[70,264,359,369],"frequency":[72],"50\u201370%.":[74],"majority":[76],"these":[78,189,395],"affect":[80],"one":[81,252,256,277],"critical":[82],"amino":[83],"acid,":[84],"resulting":[85],"V600E":[88,106,124,150,214,242,254,271,302,321,344,374,391,404,428],"substitution":[89],"which":[90],"account":[91],"for":[92],"more":[93,184],"than":[94],"90%":[95],"all":[97],"mutations.":[99],"Given":[100,210],"high":[102],"incidence":[103],"mutation":[107,147],"melanoma,":[109],"patient":[110],"management":[111],"based":[113],"on":[114,158],"use":[116],"specific":[118,272,382],"inhibitors":[119,233,383],"when":[120],"patients":[121],"carry":[122],"mutation.":[125],"By":[126],"comparing":[127],"RNA-seq":[128],"DNA":[130,152,181,408],"Sanger":[131],"sequencing":[132,154],"data,":[133],"we":[134,217],"that":[136,163,188,398],"among":[137],"cell":[140,165,190,226,244,250,260,282,317,346,354,400],"lines":[141,166,191,227,261,318,355,401],"3":[142],"were":[143,262,296],"discordant":[144,225,249,316,353],"detection":[148],"(BRAF":[149],"at":[151,173,179,324,335,406],"level/Sanger":[153],"WT":[157,171,208,239,258],"RNA-seq).":[159],"We":[160],"initially":[161],"postulated":[162],"those":[164],"may":[167,202,228,410,421],"express":[168,192],"only":[169],"allele":[172],"RNA":[175,198,215,303,326,429],"level":[176,195,329,338,409],"although":[177,334],"level.":[182],"A":[183],"careful":[185],"analysis":[186],"showed":[187,319],"very":[193],"low":[194,212],"expression":[201,306,322],"be":[203,422],"favor":[205],"allele.":[209],"expression,":[216],"tested":[218],"this":[220],"study":[221],"whether":[222],"three":[224,248,265,315],"respond":[229,411],"differently":[230,412],"to":[231,235,299,308,341,379,388,413,424],"BRAF-specific":[232],"compared":[234,340,387],"concordant":[237],"control":[243,259,345],"lines.":[245],"Methods":[246],"lines,":[251],"treated":[263],"inhibitors,":[267],"including":[268],"two":[269],"(vemurafenib":[273],"PLX4720)":[275],"aspecific":[278],"(sorafenib).":[279],"Measurement":[280],"proliferation":[283,349],"was":[284,364,384],"performed":[285,298],"MTT":[287],"assay.":[288],"Quantitative":[289],"real":[290],"time":[291],"PCR":[292],"Western":[294],"Blot":[295],"also":[297],"detect":[300],"assess":[309],"MAPK":[310,331],"activation.":[312],"Results":[313],"both":[323],"lower":[337,385,426],"as":[339,386],"line.":[347],"rate":[350],"decreased":[356],"after":[357],"treatment":[358,368,416],"vemurafenib":[360],"PLX4720":[362],"but":[363],"not":[365],"affected":[366],"sorafenib,":[370],"suggesting":[371],"biological":[375],"behavior.":[376],"Yet,":[377],"responsiveness":[378,420],"control.":[392],"All":[393],"together":[394],"data":[396],"suggest":[397],"carrying":[402],"targeted":[415],"differential":[419],"related":[423],"expression.":[432]},"counts_by_year":[{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2017-01-06T00:00:00"}